The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Correction (v159,p1621)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Wilk, C. M.
* Articles by Buchanan, R. W.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Wilk, C. M.
* Articles by Buchanan, R. W.
Related Collections
* Neuropsychology
* Schizophrenia Spectrum Disorders
* Tests
Am J Psychiatry 159:838-844, May 2002
© 2002 American Psychiatric Association


Article

Test-Retest Stability of the Repeatable Battery for the Assessment of Neuropsychological Status in Schizophrenia

Christopher M. Wilk, M.A., James M. Gold, Ph.D., John J. Bartko, Ph.D., Faith Dickerson, Ph.D., Wayne S. Fenton, M.D., Michael Knable, D.O., Christopher Randolph, Ph.D., and Robert W. Buchanan, M.D.

OBJECTIVE: The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) was designed as a cognitive screening test, providing both a total scale score and five specific cognitive ability index scores. This study examined the test-retest stability of the RBANS in individual patients with schizophrenia relative to a healthy comparison group. METHOD: A total of 181 patients with schizophrenia or schizoaffective disorder were recruited from three clinical settings. Healthy comparison subjects were recruited as part of the RBANS standardization. Participants were administered one form of the RBANS on one occasion and another form at a later date, with intervals ranging from 1 to 134 days. RESULTS: Intraclass correlation coefficients for the RBANS total scale were 0.84 for the patients with schizophrenia and 0.77 for the healthy comparison subjects. Confidence intervals and percentile data for the total scale change scores were similar for both groups. CONCLUSIONS: The RBANS demonstrated reasonable intraclass correlation coefficient test-retest reliability for both schizophrenia patients and healthy comparison subjects. Confidence intervals are comparable to those previously published for the WAIS-R and Wechsler Memory Scale—Revised, suggesting that retest measurement error is not dramatically increased in the RBANS, despite the brevity of the test. These data may serve as an informative guide for using the RBANS to evaluate neuropsychological change on the level of the individual subject.




This article has been cited by other articles:


Home page
Am. J. PsychiatryHome page
D. A. Lewis, R. Y. Cho, C. S. Carter, K. Eklund, S. Forster, M. A. Kelly, and D. Montrose
Subunit-Selective Modulation of GABA Type A Receptor Neurotransmission and Cognition in Schizophrenia
Am J Psychiatry, December 1, 2008; 165(12): 1585 - 1593.
[Abstract] [Full Text] [PDF]


Home page
AM J ALZHEIMERS DIS OTHER DEMENHome page
M. Schmitter-Edgecombe, J. T. Howard, S. P. Pavawalla, L. Howell, and A. Rueda
Multidyad Memory Notebook Intervention for Very Mild Dementia: A Pilot Study
American Journal of Alzheimer's Disease and Other Dementias, October 1, 2008; 23(5): 477 - 487.
[Abstract] [PDF]


Home page
Schizophr BullHome page
D. Dickinson and J. M. Gold
Less Unique Variance Than Meets the Eye: Overlap Among Traditional Neuropsychological Dimensions in Schizophrenia
Schizophr Bull, May 1, 2008; 34(3): 423 - 434.
[Abstract] [Full Text] [PDF]


Home page
PsychosomaticsHome page
D. Dickinson, J. M. Gold, F. B. Dickerson, D. Medoff, and L. B. Dixon
Evidence of Exacerbated Cognitive Deficits in Schizophrenia Patients With Comorbid Diabetes
Psychosomatics, April 1, 2008; 49(2): 123 - 131.
[Abstract] [Full Text] [PDF]


Home page
Br. J. PsychiatryHome page
M. S. Kraus and R. S. E. Keefe
Cognition as an outcome measure in schizophrenia
The British Journal of Psychiatry, August 1, 2007; 191(50): s46 - s51.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
A. Olincy, J. G. Harris, L. L. Johnson, V. Pender, S. Kongs, D. Allensworth, J. Ellis, G. O. Zerbe, S. Leonard, K. E. Stevens, et al.
Proof-of-Concept Trial of an {alpha}7 Nicotinic Agonist in Schizophrenia.
Arch Gen Psychiatry, June 1, 2006; 63(6): 630 - 638.
[Abstract] [Full Text] [PDF]


Home page
Evid. Based Ment. HealthHome page
B. Weber
RBANS has reasonable test-retest reliability in schizophrenia
Evid. Based Ment. Health, February 1, 2003; 6(1): 22 - 22.
[Full Text] [PDF]


Home page
Psychiatr. Serv.Home page
M. R. Serper and M. H. Allen
Emergency Psychiatry: Rapid Screening for Cognitive Impairment in the Psychiatric Emergency Service: I. Cognitive Screening Batteries
Psychiatr Serv, December 1, 2002; 53(12): 1527 - 1529.
[Full Text] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 2002 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org